Taken together, PDLIM1 can interact with E-cadherin/β-catenin complex, thereby suppressing the transcriptional activity of β-catenin and inhibiting the occurrence of EMT in CRC (Figure 3). Here, CDH1 is linked to colorectal carcinoma.